• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

海洋来源 SCSIO ZH16Δ 的抗结核伊来霉素

Antitubercular Ilamycins from Marine-Derived SCSIO ZH16 Δ.

机构信息

CAS Key Laboratory of Tropical Marine Bio-resources and Ecology, Guangdong Key Laboratory of Marine Materia Medica, RNAM Center for Marine Microbiology, South China Sea Institute of Oceanology, Chinese Academy of Sciences, 164 West Xingang Road, Guangzhou 510301, China.

Tuberculosis Research Laboratory, State Key Laboratory of Respiratory Disease, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, 190 Kaiyuan Avenue, Science Park, Huangpu District, Guangzhou 510530, China.

出版信息

J Nat Prod. 2020 May 22;83(5):1646-1657. doi: 10.1021/acs.jnatprod.0c00151. Epub 2020 Apr 23.

DOI:10.1021/acs.jnatprod.0c00151
PMID:32324401
Abstract

Tuberculosis (TB) ranks as the leading cause of death from a single infectious agent (ranking more lethal than HIV/AIDS) over the course of the past decade. More concerning is that reports of multi-drug-resistant (MDR) and extensively drug-resistant (XDR) strains of TB have been dramatically increasing. It continues to become ever more clear that novel anti-TB drugs with improved efficacies and reduced toxicities are urgently needed. We report here the discovery of 12 new ilamycin analogues, ilamycins G-R (-), bearing various nonproteinogenic amino acids, along with ilamycins E () and F (), from a 200 L scale culture of the marine-derived mutant actinomycete SCSIO ZH16 Δ. Importantly, bioassays against H37Rv revealed that all 12 new agents displayed antitubercular activities with MIC values ranging from 0.0096 to 10 μM. The structures of - were elucidated on the basis of HRESIMS, 1D and 2D NMR, and X-ray single-crystal diffraction studies. In addition, compound was found to be moderately cytotoxic against a panel of tumor human cell lines. From these data we can formulate tentative structure-activity relationships for the antitubercular and antitumor activities of the ilamycins.

摘要

结核病 (TB) 在过去十年中一直是单一感染源导致死亡的主要原因(比 HIV/AIDS 更致命)。更令人担忧的是,耐多药 (MDR) 和广泛耐药 (XDR) 结核菌株的报告数量急剧增加。显然,需要具有更高疗效和更低毒性的新型抗结核药物。我们在此报告了 12 种新的伊拉霉素类似物,即 ilamycins G-R (-),它们带有各种非蛋白氨基酸,以及 ilamycins E () 和 F (()),这些化合物是从海洋来源的突变放线菌 SCSIO ZH16 Δ 的 200 L 规模培养物中分离得到的。重要的是,对 H37Rv 的生物测定表明,所有 12 种新化合物均具有抗结核活性,MIC 值范围为 0.0096 至 10 μM。基于 HRESIMS、1D 和 2D NMR 以及 X 射线单晶衍射研究,确定了 - 的结构。此外,化合物 对一组肿瘤人类细胞系表现出中等细胞毒性。根据这些数据,我们可以制定伊拉霉素的抗结核和抗肿瘤活性的暂定结构-活性关系。

相似文献

1
Antitubercular Ilamycins from Marine-Derived SCSIO ZH16 Δ.海洋来源 SCSIO ZH16Δ 的抗结核伊来霉素
J Nat Prod. 2020 May 22;83(5):1646-1657. doi: 10.1021/acs.jnatprod.0c00151. Epub 2020 Apr 23.
2
Combinatorial strategies for production improvement of anti-tuberculosis antibiotics ilamycins E/E from deep sea-derived Streptomyces atratus SCSIO ZH16 ΔilaR.提高源自深海阿特拉链霉菌SCSIO ZH16 ΔilaR的抗结核抗生素伊拉霉素E/E产量的组合策略。
Bioresour Bioprocess. 2022 Oct 22;9(1):111. doi: 10.1186/s40643-022-00599-z.
3
Semi-Synthesis of Marine-Derived Ilamycin F Derivatives and Their Antitubercular Activities.海洋来源的伊拉霉素F衍生物的半合成及其抗结核活性。
Front Chem. 2021 Oct 29;9:774555. doi: 10.3389/fchem.2021.774555. eCollection 2021.
4
Biosynthesis of ilamycins featuring unusual building blocks and engineered production of enhanced anti-tuberculosis agents.具有不寻常结构单元的伊拉霉素生物合成和增强抗结核药物的工程化生产。
Nat Commun. 2017 Aug 30;8(1):391. doi: 10.1038/s41467-017-00419-5.
5
Efficient ilamycins production utilizing Enteromorpha prolifera by metabolically engineered Streptomyces atratus.利用经代谢工程改造的深绿链霉菌,以浒苔高效生产伊拉霉素。
Biotechnol Biofuels Bioprod. 2023 Oct 5;16(1):151. doi: 10.1186/s13068-023-02398-w.
6
Characterization of Regulatory and Transporter Genes in the Biosynthesis of Anti-Tuberculosis Ilamycins and Production in a Heterologous Host.抗结核伊拉菌素生物合成中调控和转运基因的特性及其在异源宿主中的生产。
Mar Drugs. 2020 Apr 17;18(4):216. doi: 10.3390/md18040216.
7
Genome Mining of Streptomyces atratus SCSIO ZH16: Discovery of Atratumycin and Identification of Its Biosynthetic Gene Cluster.链霉菌属atratus SCSIO ZH16 的基因组挖掘:阿特拉霉素的发现及其生物合成基因簇的鉴定。
Org Lett. 2019 Mar 1;21(5):1453-1457. doi: 10.1021/acs.orglett.9b00208. Epub 2019 Feb 12.
8
Design, synthesis and investigation on the structure-activity relationships of N-substituted 2-aminothiazole derivatives as antitubercular agents.N-取代2-氨基噻唑衍生物作为抗结核药物的设计、合成及构效关系研究
Eur J Med Chem. 2014 Jan 24;72:26-34. doi: 10.1016/j.ejmech.2013.11.007. Epub 2013 Nov 13.
9
Antimycobacterial Rufomycin Analogues from Strain MJM3502.来自 MJM3502 菌株的抗分枝杆菌罗芙木碱类似物。
J Nat Prod. 2020 Mar 27;83(3):657-667. doi: 10.1021/acs.jnatprod.9b01095. Epub 2020 Feb 7.
10
Production of Antitubercular Depsipeptides via Biosynthetic Engineering of Cinnamoyl Units.通过肉桂酰基单元的生物合成工程生产抗结核二肽。
J Nat Prod. 2020 May 22;83(5):1666-1673. doi: 10.1021/acs.jnatprod.0c00194. Epub 2020 Apr 27.

引用本文的文献

1
Harnessing Actinobacteria secondary metabolites for tuberculosis drug discovery: Historical trends, current status and future outlooks.利用放线菌次生代谢产物进行结核病药物发现:历史趋势、现状与未来展望。
Nat Prod Bioprospect. 2025 Aug 11;15(1):52. doi: 10.1007/s13659-025-00533-8.
2
Total Synthesis of Mycoplanecin A.霉菌平面霉素A的全合成
Org Lett. 2025 Aug 15;27(32):9061-9065. doi: 10.1021/acs.orglett.5c02803. Epub 2025 Aug 1.
3
Total Syntheses of Stereoisomeric Congeners of Rufomycin Natural Products Having Anti-Mycobacterial Activity.
具有抗分枝杆菌活性的鲁佛霉素天然产物立体异构体同系物的全合成。
Org Lett. 2025 Jun 20;27(24):6342-6348. doi: 10.1021/acs.orglett.5c01525. Epub 2025 Jun 6.
4
Diversity of secondary metabolites from marine Streptomyces with potential anti-tubercular activity: a review.具有潜在抗结核活性的海洋链霉菌次级代谢产物的多样性:综述
Arch Microbiol. 2025 Feb 17;207(3):64. doi: 10.1007/s00203-024-04233-8.
5
Enhancing rufomycin production by CRISPR/Cas9-based genome editing and promoter engineering in sp. MJM3502.通过基于CRISPR/Cas9的基因组编辑和启动子工程提高链霉菌MJM3502中鲁夫霉素的产量。
Synth Syst Biotechnol. 2025 Jan 17;10(2):421-432. doi: 10.1016/j.synbio.2025.01.002. eCollection 2025 Jun.
6
Brevianamide F Exerts Antithrombotic Effects by Modulating the MAPK Signaling Pathway and Coagulation Cascade.布瑞维亚胺 F 通过调节 MAPK 信号通路和凝血级联发挥抗血栓作用。
Mar Drugs. 2024 Sep 26;22(10):439. doi: 10.3390/md22100439.
7
Recent Advances in Marine-Derived Compounds as Potent Antibacterial and Antifungal Agents: A Comprehensive Review.海洋来源化合物作为强效抗菌和抗真菌剂的最新进展:全面综述。
Mar Drugs. 2024 Jul 29;22(8):348. doi: 10.3390/md22080348.
8
Rapid Peptide Cyclization Inspired by the Modular Logic of Nonribosomal Peptide Synthetases.受非核糖体肽合成酶模块化逻辑启发的快速肽环化
J Am Chem Soc. 2024 Jun 6;146(24):16787-801. doi: 10.1021/jacs.4c04711.
9
Recent Advances in Polypeptide Antibiotics Derived from Marine Microorganisms.海洋微生物来源的多肽抗生素研究进展。
Mar Drugs. 2023 Oct 22;21(10):547. doi: 10.3390/md21100547.
10
Targeting iron-scavenging tools: a recent update on siderophores inhibitors.靶向铁清除工具:铁载体抑制剂的最新进展
RSC Med Chem. 2023 Sep 6;14(10):1885-1913. doi: 10.1039/d3md00201b. eCollection 2023 Oct 18.